COVID-19 Vaccines and Monoclonal Antibody Therapies

February 9, 2021 • 6:00 p.m. - 7:15 p.m.

Join PMDA for an evening with Dr. David Nace, AMDA President, as he dives deep into the COVID-19 vaccines and monoclonal antibody therapies in the LTC setting.

This interactive session will review information on the use of monoclonal antibodies and currently authorized vaccines for the treatment and prevention of COVID-19 in the post-acute and long-term care setting. The session will consist of didactic presentation followed by an open question and answer session.

By the end of the presentation, participants should be able to:

1. Discuss the evidence-based supporting use of monoclonal antibodies in the treatment of COVID-19
2. Describe the challenges to using monoclonal antibodies in the LTC setting
3. List the risks and benefits of current COVID-19 vaccines
4. Discuss challenges to delivering COVID-19 vaccines in the LTC Setting

Details and Registration